e-learning
resources
Stockholm 2007
Wednesday 19.09.2007
Biology in thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The ability of autologous dendritic cells to destroy NSCLC cells
in vitro
O. Jankowska, P. Krawczyk, D. Sagan, J. Milanowski (Lublin, Poland)
Source:
Annual Congress 2007 - Biology in thoracic oncology
Session:
Biology in thoracic oncology
Session type:
Oral Presentation
Number:
4239
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Jankowska, P. Krawczyk, D. Sagan, J. Milanowski (Lublin, Poland). The ability of autologous dendritic cells to destroy NSCLC cells
in vitro
. Eur Respir J 2007; 30: Suppl. 51, 4239
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Human myeloid lung dendritic cells are strong inducers of T cell proliferation compared to plasmacytoid lung dendritic cells
Source: Annual Congress 2005 - Basic mechanisms in asthma and COPD: new insights
Year: 2005
Influence of tumour cell lysate on state of lymphocytes‘ activation after DCs stimulation in lung cancer
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
Expression and function of toll like receptors on human lung dendritic cells
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006
Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Accumulation of differentiated CD8
+
T cells specific for respiratory viruses in the human lung
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006
EpCAM-positive circulating cells in lung cancer patients
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Cellular reprogramming of cancer cells to antigen-presenting cells
Source: ERS Lung Science Conference 2021
Year: 2021
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis in resected non–small cell lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009
Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival
Source: Eur Respir J 2009; 33: 118-126
Year: 2009
Extracts of lung cancer cells reveal antitumour antibodies in sera of patients with lung cancer
Source: Eur Respir J 2003; 21: 342-346
Year: 2003
Dendritic cells stimulated by agonistic anti-CD40 mAb could elicit activation of lung cancer patients’ autologous cytotoxic T lymphocytes
Source: Eur Respir J 2004; 24: Suppl. 48, 673s
Year: 2004
Identification of a candidate progenitor cell for dendritic cells and other antigen-presenting cells within in the mouse respiratory tract
Source: Annual Congress 2006 - Immunology of the airways
Year: 2006
The expression and clinical significance of PD-L1
+
CD68
+
macrophages in peripheral blood mononuclear cells of non-small cell lung cancer
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Anti-tumour effects of coculture of dendritic cells with cytokine-induced killer cells against lung cancer
in vitro
and
in vivo
Source: Eur Respir J 2006; 28: Suppl. 50, 387s
Year: 2006
Heparins inhibit lung cancer cells proliferation in vitro
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Cytotoxic T cell antigen 4 and the status of T cell activation in lung cancer: local vs. systemic immune response.
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017
Circulating CD133(+) stem cells in lung cancer patients
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Identification and characterisation of isolated human lung dendritic cells (DCs)
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006
Lower APCR correlates with apoptotic activation of CD8+T cells in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 356s
Year: 2004
Modulation of tumor-microenvironmental factors and cancer growth in co-cultures of fresh human lung tissue and patient-derived cancer cells
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept